IMU 4.00% 4.8¢ imugene limited

Clearly the MC of $3.5B was way overvalue given HER-Vaxx wasn't...

  1. 27,364 Posts.
    lightbulb Created with Sketch. 1777
    Clearly the MC of $3.5B was way overvalue given HER-Vaxx wasn't even close to Ph2 completion and clearly MC of $440M is undervalue given the other IP development and HER-Vaxx has completed Ph2.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.